REN and hypertensive disorder: This could implicate radically different levels of pressor pathways activation (renin increase, afferent sympathetic nerve activation and hypertension, tissue hypoxia, inflammation, injury, and fibrosis), resulting in different outcomes of invasive RAS treatment [1].